Asahi Kasei Pharma Corp. Company Profile

20:45 EST 21st November 2014 | BioPortfolio

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. www.akpamerica.com


News Articles [1442 Associated News Articles listed on BioPortfolio]

Asahi Kasei Corporation: Company Profile and SWOT Analysis

Recently added to the BioPortfolio report store, Asahi Kasei Corporation: Company Profile and SWOT Analysis is a new report from ICD Research published on 2011-09-09. This 35-page report is availabl...

Asahi Kasei Zoll Medical obtains Japanese approval for R Series Monitor/Defibrillator

Asahi Kasei Zoll Medical (AZM), the Japanese subsidiary of Zoll Medical, has obtained Shonin approval from the Japanese Ministry of Health, Labour and Welfare for its R Series Monitor/Defibrillator.

Asahi Kasei Kuraray Medical Co., Ltd. - Medical Equipment - Deals and Alliances Profile

Recently added to the BioPortfolio report store, Asahi Kasei Kuraray Medical Co., Ltd. - Medical Equipment - Deals and Alliances Profile is a new report from GlobalData published on 2014-10-28. This ...

ZOLL Announces the Acquisition of Philips InnerCool Temperature Management

Expands ZOLL’s Temperature Management Portfolio ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has signe...

ZOLL Announces Acquisition of the Assets of Impact Instrumentation, Inc.

Expands ZOLL’s Lifesaving Products for Military Personnel ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it...

Zoll buys Impact Instrumentation

Asahi Kasei Corp.’s Zoll Medical Corp. acquired respiratory care product manufacturer Impact Instrumentation Inc. for an undisclosed sum.

Zoll Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market the R Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has recei...

ZOLL Files with Japan’s Pharmaceuticals and Medical Devices Agency for New Indication for Intravascular Temperature Management Technology

Approval Sought to Use Temperature Management for Sudden Cardiac Arrest ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, anno...

Drugs and Medications [239 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Investigation into mixing capability and solid dispersion preparation using the DSM Xplore Pharma Micro Extruder.

The goal of this investigation was to qualify the DSM Xplore Pharma Micro Extruder as a formulation screening tool for early-stage hot-melt extrusion.

Pharma corruption.

The premium of a big pharma license deal.

Big pharma in the dock over patent law plot in South Africa.

Clinical Trials [43 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients

The main purpose of this longitudinal study is to point out the effect of VitabranE on the ESA resistance and on the anemia observed in HD patients undergoing EPO maintenance therapy. As ...

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Companies [648 Associated Companies listed on BioPortfolio]

Asahi Kasei Pharma Corp.

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Pharma America

Asahi Kasei Pharma America (AKP America), a wholly owned subsidiary of Asahi Kasei Pharma, Corp., is a biopharmaceutical company dedicated to bringing best-in-class critical care ...

Asahi Kasei Corporation

Asahi Kasei Corporation, with consolidated sales of US$10 billion, provides innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, con...

Sankyo Kasei Co., Ltd.

Maeda Chemical Industry Co. merged with Asahi Chemical Industry Co. to establish Sankyo Kasei Co.Capital: ¥30 millionCapital increase: ¥50 million Sodium hydrosulfide plant completed (Akitsu Plant) ...

Rakuto Kasei Ltd

Rakuto Kasei(Israel) Ltd. was established in 1990 as a joint venture with Rakuto Kasei Industrial Co. Japan, a leading worldwide producer of enzymes. Based on over 20 years of experience in the field ...

More Information about "Asahi Kasei Pharma Corp." on BioPortfolio

We have published hundreds of Asahi Kasei Pharma Corp. news stories on BioPortfolio along with dozens of Asahi Kasei Pharma Corp. Clinical Trials and PubMed Articles about Asahi Kasei Pharma Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asahi Kasei Pharma Corp. Companies in our database. You can also find out about relevant Asahi Kasei Pharma Corp. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record